Authors

• Rupesh Kotecha, Wertheim Cancer InstituteFollow
• Haley Appel, Wertheim Cancer InstituteFollow
• Antoinette Pimentel, Wertheim Cancer InstituteFollow
• Amy Starosciak, Wertheim Cancer InstituteFollow
• Muni Rubens, Baptist Health South FloridaFollow
• Mukesh Roy, Wertheim Cancer InstituteFollow
• Dilanis Perche, Wertheim Cancer InstituteFollow
• Ramon Cruz, Wertheim Cancer InstituteFollow
• Matthew Hall, Wertheim Cancer InstituteFollow
• Ana Botero, Wertheim Cancer InstituteFollow
• Minesh Mehta, Wertheim Cancer InstituteFollow
• Justin Sporrer, Miami Neuroscience InstituteFollow
• Brian Schiro, Wertheim Cancer InstituteFollow

Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: A phase 2 randomized controlled trial

Publication Date

1-1-2026

Content Type

article

PubMed ID:

41056433

Additional Authors:

Additional Authors and Institutional Affiliations

Citation

Kotecha, R., Gal, O., Appel, H., Avendano, M. C., Pimentel, A. M., Starosciak, A. K., Rubens, M., Roy, M., Perche, D., Pow-Sang, C. I., Milosevic, F., Cruz, R. F., Kudryashev, A., Hall, M. D., Botero, A., Mehta, M. P., Sporrer, J. M., & Schiro, B. J. (2026). Radiation therapy alone versus radiation therapy plus radiofrequency ablation/vertebral augmentation for painful spine metastasis: A phase 2 randomized controlled trial. Neuro-oncology, 28(1), 241–250. https://doi.org/10.1093/neuonc/noaf231